October 2026 FDA Recall Drug by Greenwich Rx
D-0084-2027 - Microbial Contamination of Sterile Products

This Class I drug recall was voluntarily initiated by Greenwich Rx on October 1, 2026 for the product Drug. The FDA reported the reason for recall as microbial contamination of sterile products. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0084-2027

Reason for Recall
Microbial Contamination of Sterile Products
Initiated
10-01-2026
Reported
10-28-2026
Quantity
4,319 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
US Nationwide in th USA
Glutathione Injection (Glutathione-L, Ascorbic Acid, Sodium Hydroxide, Bacteriostatic Water), 200 mg/mL, 10 mL multi-dose vial, Rx only, Subcutaneous Only, Greenwich Rx.

Batch or Lot Expiration Information

Lot# 0060-062426-1, BUD: 10/02/2026
Lot# 0060-062726-1, BUD: 10/05/2026
Lot# 0060-070926-1, BUD: 10/17/2026
Lot# 0060-071426-1, BUD: 10/22/2026
Lot# 0060-071426-2, BUD: 10/22/2026
Lot# 0060-072026-1, BUD: 10/28/2026
Lot# 0060-072726-1, BUD: 11/04/2026
Lot# 0060-072926-1, BUD: 11/06/2026
Lot# 0060-073126-1; BUD: 11/08/2026
Lot# 0060-080426-1, BUD: 11/12/2026
Lot# : 0060-080526-1, BUD: 11/13/2026
Lot# 0060-081826-1, BUD: 11/26/2026.